WILMINGTON, Mass.--(BUSINESS WIRE)--June 6, 2006--Charles River Laboratories International, Inc. (NYSE: CRL - News), today announced the pricing of $300 million principal amount of Convertible Senior Notes due 2013 in an offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
